| name: | Cortivazol | |
| ATC code: | H02AB17 | route: | intramuscular | 
| compartments: | 1 | |
| dosage: | 3 | mg | 
| volume of distribution: | 30 | L | 
| clearance: | 1.5 | L/h | 
| other parameters in model implementation | ||
Cortivazol is a synthetic glucocorticoid corticosteroid used primarily as an anti-inflammatory and immunosuppressive agent. It was formerly used in France for disorders requiring systemic corticosteroid therapy but is not widely approved or marketed today.
Estimated pharmacokinetic parameters for a healthy adult population, as no primary pharmacokinetic clinical data published for cortivazol could be identified in available literature.